Pediatric Infectious Diseases & HIV
Since its founding in 1988, Pediatric Infectious Diseases has been providing expert consultation and care for the pediatric community. Just as our division guided advancements in care for pediatric HIV, we remain on the leading edge of care for common infections as well as new and emerging pathogens such as SARS-CoV-2, the virus that causes COVID-19.
Under the leadership of Moshe Arditi, MD, and the expertise of Santhosh Nadipuram, MD, and Priya Soni, MD, the team strives to expand the scope of care provided to all its patients. All are board certified in pediatrics and pediatric infectious diseases. In addition to clinical care, the team is dedicated to the advancement of pediatric infectious diseases through basic science and clinical research.
Pediatric Infectious Diseases and HIV offers the following services:
- Assessing and managing congenital and perinatally acquired infections (e.g., CMV, Toxoplasmosis, HSV)
- Treating complicated infections (osteomyelitis, endocarditis, severe pneumonia and empyema, as well as aggressive cellulitis and deep tissue infections)
- Evaluating and treating children with prolonged fevers (FUO)
- Treating infections with resistant organisms (community-acquired and hospital-acquired infections)
- Treating local outbreaks of infectious diseases, such as hepatitis, tuberculosis and diarrheal diseases
- Evaluating children with recurrent infections and managing children exposed to HIV and those living with AIDS
- Diagnosing and managing Kawasaki disease
- Pre- and post-adoption consultation
- Pre-travel consultation
- Management of pediatric COVID-19, multisystem inflammatory syndrome in children as well as long-term complications of COVID-19
Currently, Pediatric Infectious Diseases has a National Institutes of Health-funded research laboratory. Research interests of the Pediatric Infectious Diseases staff include:
- Mechanisms of inflammation in Kawasaki disease and other vasculitides
- The role of the gut microbiome in inflammation and immunity
- Clinical trials for the treatment and prevention of COVID-19
- Immunology and host response to COVID-19
- Pathogenesis of Toxoplasma gondii in the brain and eye
- Role of chlamydial infections in the development of atherosclerosis
The Pediatric Infectious Diseases staff works with the referring physician to determine the best course of treatment for patients with infectious diseases, providing results from their findings, as well as recommending disease management and prevention strategies. When the patient is referred back to the primary care physician for continued management, Pediatric Infectious Diseases remain available 24 hours a day, seven days a week to provide post-treatment support.
For More Information
For more information on Pediatric Infectious Diseases or to make a referral, please contact: